You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Claims for Patent: 10,953,098


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,953,098
Title:Chemical structures for localized delivery of therapeutic agents
Abstract:The present invention provides a method for selective delivery of a therapeutic or diagnostic agent to a targeted organ or tissue by implanting a biocompatible solid support in the patient being linked to a first binding agent, and administering a second binding agent to the patient linked to the therapeutic or diagnostic agent, such that the therapeutic or diagnostic agent accumulates at the targeted organ or tissue.
Inventor(s):Jose Manuel Mejia Oneto, Ziyad F. Al-Rashid
Assignee: ALCHEMICAL RESEARCH HOLDINGS LLC , University of California San Diego UCSD
Application Number:US16/149,628

Details for Patent 10,953,098

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Glaxosmithkline Biologicals SHINGRIX zoster vaccine recombinant, adjuvanted Injection 125614 October 20, 2017 ⤷  Get Started Free 2038-10-02
Glaxosmithkline Biologicals SHINGRIX zoster vaccine recombinant, adjuvanted For Injection 125614 July 23, 2021 ⤷  Get Started Free 2038-10-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.